Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Neurology|February 20, 2025
Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease (P11-9.013)Philip Scheltens, Alireza Atri, Howard Feldman, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristicsRoy W Jones, Miia Kivipelto, Howard Feldman, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 30, 2003
The Consortium to Investigate Vascular Impairment of Cognition: methods and first findingsKenneth Rockwood, Heather Davis, Chris MacKnight, et al.BMC Neurology|September 2, 2006
Familial frontotemporal dementia with neuronal intranuclear inclusions is not a polyglutamine expansion diseaseIan R Mackenzie, Stefanie L Butland, Rebecca S Devon, et al.Journal of the Neurological Sciences|December 27, 2006
Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort studyKenneth Rockwood, Paige King Moorhouse, Xiaowei Song, et al.Journal of the Neurological Sciences|October 11, 2005
Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort studyKenneth Rockwood, Sandra E Black, Xiaowei Song, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 19, 2011
Global issues in drug development for Alzheimer's diseaseRachelle S Doody, Patricia E Cole, David S Miller, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 4, 2010
Dependence as a unifying construct in defining Alzheimer's disease severityTrent McLaughlin, Howard Feldman, Howard Fillit, et al.Canadian Geriatrics Journal : CGJ|December 16, 2021
Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of AducanumabHoward Chertkow, Kenneth Rockwood, David B Hogan, et al.Brain : a Journal of Neurology|January 13, 2006
A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17Ian R Mackenzie, Matthew Baker, Gemma West, et al.Pageof 6